Clinical implications of cigarette smoking in acute myocardial infarction: Acute angiographic findings and long-term prognosis
References (21)
- et al.
Evaluation of paradoxic beneficial effects of smoking in patients receiving thrombolytic therapy for acute myocardial infarction: mechanisms of the “smoker's paradox” from the GUSTO-I Trial with angiographic insights
J Am Coll Cardiol
(1995) - et al.
How do smokers differ from nonsmokers in their response to thrombolysis? (the TIMI-4 Trial)
Am J Cardiol
(1995) - et al.
Influence of cigarette smoking on rate of reopening of the infaract-related coronary artery after myocardial infarction: a multivariate analysis
Am J Cardiol
(1996) - et al.
The use of single plane angiocardiograms for the calculation of left ventricular volume in mon
Am Heart J
(1968) - et al.
Effects of changes in smoking and other characteristics on clotting factors and the risk of ischemic heart disease
Lancet
(1987) - et al.
Does Thrombolysis in Myocardial Infarction (TIMI) perfusion grade 2 represent a mostly patent artery or mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 Study
J Am Coll Cardiol
(1992) - et al.
Effect of reperfusion modality on outcome in nonsmokers and smokers with acute myocardial infarction (a Primary Angioplasty in Myocardial Infarction [PAMI] substudy)
Am J Cardiol
(1996) - et al.
Reinfarction after thrombolytic therapy for acute myocardial infarction
J Am Coll Cardiol
(1990) - et al.
Latest perspective on cigarette smoking and cardiovascular disease: the Framingham Study
J Cardiac Rehabil
(1984) - et al.
Mortality in relation to smoking: 20 years' observations of male British doctors
Br Med J
(1976)
Cited by (32)
Meta-Analysis Comparing Outcomes of Smokers Versus Nonsmokers With Acute Coronary Syndrome Underwent Percutaneous Coronary Intervention
2018, American Journal of CardiologyCitation Excerpt :Smokers tend to present with AMI in younger age than nonsmokers. They have lower co-morbidities because of young age.1,2 They tend to quit smoking as they age and develop other cardiovascular risk factors.23
No correlation between body mass index and 30-day prognostic outcome in Asians with acute ST-elevation myocardial infarction undergoing primary coronary intervention
2017, Biomedical JournalCitation Excerpt :Intriguingly, the paradoxical effects of smoking and higher blood pressure on better prognostic outcome in acute coronary syndrome patients have also been reported in some previous studies [39–42]. Tentative explanations for these paradoxical effects have been identified [16,23–28,39–42]. The most important finding in the present study was that neither normal weight and overweight, nor obesity was significantly predictive of 30-day mortality or 30-day MACO.
"Smoker's paradox" and reperfusion's strategy in acute myocardial infarction
2010, Annales de Cardiologie et d'AngeiologiePlanned Versus Provisional Use of Glycoprotein IIb/IIIa Inhibitors in Smokers Undergoing Percutaneous Coronary Intervention
2006, American Journal of CardiologyCitation Excerpt :Moreover, this difference was not observed in REPLACE-1, where GP IIb/IIIa inhibition was used consistently with bivalirudin, suggesting an important role for GP IIb/IIIa inhibitors in subpopulations of smokers who undergo PCI. In our study, we found no significant differences in 30-day ischemic event rates between current smokers and nonsmokers, despite numerous reports of a smoker’s paradox15–23 and more favorable baseline characteristics of the current smokers (unpublished data). Compared with nonsmokers, smokers in our study were younger and developed fewer co-morbidities and coronary risk factors, with the exception of previous MI (Table 1).
- 1
From the Department of Cardiology, Hiroshima City Hospital.